Valliant John

Valliant John is listed in filings as Chief Executive Officer at Fusion Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 4, 2024, including 12 public disclosures. Recent filings connect the profile to Fusion Pharmaceuticals Inc. (FUSN). The current snapshot covers public activity from Jan 5, 2024 to Jun 4, 2024. Reported amounts are shown as $6.7M to $4.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.